Category

Cohort News

Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics

//
Categories
Latest fundraising efforts accelerate further innovation in biology-based diagnostics and therapeutics for critical care conditions CHICAGO, IL – January 29, 2026 – Prenosis, a biology-based technology company delivering integrated diagnostics and therapeutics, announced today two major milestones: completion of its...
Read More →

Evaluation of a machine learning system for genomic antimicrobial susceptibility determination on a clinically representative test set featuring Day Zero Diagnostics

//
Categories
ABSTRACT Next-generation sequencing is anticipated to transform infectious disease treatment by enabling faster diagnosis, yet a clinical-grade method for genomic AST determination is still lacking. We assessed the accuracy of Keynome gAST, a k-mer based machine learning system for genomic...
Read More →
1 2 3 153